Selection from HEOR Bibliography

IMS logo
Search criteria
Country: Korea
 
Risk Factors and Medical Resource Utilization of Respiratory Syncytial Virus, Human Metapneumovirus and Influenza Related Hospitalizations in Adults – A Global Study During the 2017-2019 Epidemic Seasons (Hospitalized Acute Respiratory Tract Infection [HARTI] Study)
Authors: Ann R Falsey, Edward E Walsh, Stacey House, Yannick Vandenijck, Xiaohui Ren, Sofia Keim, Diye Kang, Pascale Peeters, James Witek, Gabriela Ispas
Affiliations: University Of Rochester School Of Medicine and Rochester Regional Health, Rochester, NY, United States; Washington University School of Medicine, St Louis, MO, United States; Janssen Infectious Diseases, Beerse, Belgium; IQVIA Real-World Solutions, Courbevoie, France; Janssen Research & Development, LLC, Titusville, NJ, United States
Publications: 
Document Types: , Article
Countries: , Argentina, Australia, Brazil, Canada, France, Germany, Japan, Korea, Malaysia, Mexico, South Africa, USA
Abstract: https://academic.oup.com/ofid/advance-article/doi/10.1093/ofid/ofab491/6381446
Condition Year Language Analysis type
, Infectious disease 2021 English , Burden of illness, Clinical setting: hospital, Epidemiological study, Observational study, Patient questionnaire, Prospective study
 
 
Benzodiazepine prescribing in the elderly in Germany and Korea: A comparison of two observational studies
.
Authors: Woodcock BG, Kostev K, Shin JY
Affiliations: 
Publications: 
Int J Clin Pharmacol Ther. 2017 May 10. doi: 10.5414/CP203042. [Epub ahead of print]
Document Types: , Article
Countries: , Germany, Korea
Condition Year Language Analysis type
, Mental health 2017 English , Observational study
 
 
Evolution of oral anticancer treatments use in France from 2004 to 2012: the Re-ACTOR Study.
Authors: Benjamin L, Maurel F, Bardoulat I, Ricarte C
Affiliations: 1 Glaxosmithkline, 2 Health Economics and Outcomes Research, Marly le Rol, France, 3 IMS Health, La Defense, France
Publications: 
ISPOR Europe 2013 Annual meeting
Document Types: , Poster
Countries: , China, France, Germany, Italy, Japan, Korea, Spain, Taiwan, UK
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(13)02489-3/fulltext
Condition Year Language Analysis type
, Oncology 2013 English , Retrospective database analysis
 
 
Current situation of oral anticancer treatments use in France: the ACTOR Study.
Authors: Benjamin L, Maurel F, Bardoulat I, Ricarte C
Affiliations: 1 Glaxosmithkline, 2 Health Economics and Outcomes Research, Marly le Rol, France, 3 IMS Health, La Defense, France
Publications: 
ISPOR Europe 2013 Annual meeting
Document Types: , Abstract
Countries: , China, France, Germany, Italy, Japan, Korea, Spain, Taiwan, UK
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(13)02492-3/fulltext
Condition Year Language Analysis type
, Oncology 2013 English
 
 
Evaluation of the willingness-to-pay for cancer treatment in Korean metastatic breast cancer patients: a multicenter, cross-sectional study.
Authors: Do-Youn OH 1, Bruce CRAWFORD6, Sung-Bae KIM 2, Hyun-Cheol CHUNG 3, Jeffrey MCDONALD 6, Sang Yoon LEE 4, Su-Kyoung KO4 andJungsil RO 5
Affiliations: 1 Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine 2 Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine 3 Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Yonsei University Health System 4 Pfizer Korea, Seoul 5 Center for Breast Cancer, National Cancer Center, Goyang, Korea 6 Adelphi Values, Tokyo, Japa
Publications: 
Asia Pac J Clin Oncol. 2012 Sep;8(3):282-91. doi: 10.1111/j.1743-7563.2012.01546.x. Epub 2012 May 21.
Document Types: , Article
Countries: , Korea
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22898238
Condition Year Language Analysis type
, Oncology 2012 English , Burden of illness, Survey research
 
 
An economic evaluation of drospirenone 2 mg/estradiol 1.033 mg versus tibolone 2.5mg in the treatment of postmenopausal women with grade 1 or 2 hypertension in Korea
Authors: Jung S1, Watson P2, Asukai Y3, Jeong M4
Affiliations: 1 Bayer Korea, Seoul, South Korea 2 IMS Health, London, UK
Publications: 
ISPOR 12th Annual European Congress 2009, 24 to 27 October, Paris, France
Document Types: , Poster
Countries: , Korea
Condition Year Language Analysis type
, Womens Health 2009 English , , Economic evaluation
 
 
Cost-Effectiveness Of Rivaroxaban Versus Enoxaparin For Prophylaxis After Total Hip Or Total Knee Replacement In Korea
Authors: Kim J1, Pollock R2, Jung S3, Diamantopoulos A4, Lees M5
Affiliations: 1IMS Health, Seoul, South Korea, 2IMS Health, Basel, Switzerland, 3Bayer Korea, Seoul, South Korea, 4IMS Health, London, UK, 5Bayer HealthCare, Uxbridge, UK
Publications: 
ISPOR 14th Annual International Meeting, Orlando, Florida, USA May 16-20, 2009
Document Types: , Poster
Countries: , Korea
Condition Year Language Analysis type
, Cardiovascular disease 2009 English , Cost effectiveness
 
 
Copyright © 2021 IMS Health Incorporated. All rights reserved.